2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$24.43+$0.45 (+1.86%)
Price as of Aug 21, 2026 7:30 PM EDT- $174.2MMarket Cap
- -3.23%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$24.43+$0.45 (+1.86%)
Earnings Score
Valuation | CUE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -0 | ||
Growth | 0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CUE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 63.00% | ||
12-Month Momentum | 35.94% | ||
3-Month Risk Adjusted Momentum | 118.11% | ||
12-Month Risk Adjusted Momentum | 18.72% |
True Yield
Valuation | CUE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.0001% | ||
Net Debt Paydown Yield | -21.25% |
Financial Health Score
Valuation | CUE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |